Patentable Subject Matter Post Alice Corp. v. CLS BankShare
8:00 a.m. to 8:30 a.m. Registration and continental breakfast
8:30 a.m. to 12:00 p.m. Symposium and panel discussion
12:00 p.m. to 1:00 p.m. Lunch in Auerbach Commons
The Supreme Court’s Alice Corp. v. CLS Bank decision was intended to clarify the patent eligible subject matter test under 35 U.S.C. § 101. The decision purported to resolve the issue of whether an abstract idea is patentable, or whether something more is required to render it patent eligible. The aftermath has been anything but clear. To some observers, the test has been reduced to a murky and unpredictable "you’ll know it when you see it" standard.
Our panelists will help business and legal professionals better understand current patent eligibility standards and make informed patent strategy decisions going forward.
Topics will include:
- 35 U.S.C. § 101 and Patent Eligible Subject Matter Post Alice.
- Patent Prosecution Strategy and Decision Making
- Patent Litigation Strategy and Decision Making
In addition, we will provide updates on the following topics of current interest in patent law:
- Post Grant Review and Inter Parties Review -"Where Are We Now?" Updates on Rules, Board Decisions, and Practice Pointers.
- The Top Patent Law Developments Not Relating to Alice, including the Supreme Court’s Teva decision modifying the longstanding standard of review applicable to patent claim construction.
Speakers and Panel Members:
- Thomas Cotter, University of Minnesota, Briggs and Morgan, Professor of Law
- Scott Flaherty, Shareholder, Briggs and Morgan, P.A.
- Michael Lafeber, Shareholder, Briggs and Morgan, P.A.
- Scott Marks, Senior Intellectual, Property Attorney, St. Jude Medical
- Karen McDaniel, Shareholder, Briggs and Morgan, P.A.
- Dan Rosenberg, Shareholder, Briggs and Morgan, P.A.